logo

For the Inventor, By the Inventor

North Stonington, CT, United States of America

Stevin H Zorn

This inventor holds 4 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 1999-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stevin H Zorn. Retrieved from https://idiyas.com/inventor/stevin-h-zorn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 50.0

Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 46(Granted Patents)


Location History:

  • North Stonington, CT (US) (1999 - 2003)
  • No. Stonington, CT (US) (2003)

Company Filing History:

goldMedal4 out of 4,486 
 
Pfizer Corporation
 patents

Years Active: 1999-2003

Loading Chart...
4 patents (USPTO):Explore Patents
1. 6608064 - Pharmaceutical agents for the treatment of Parkinson's disease, ADHD and microadenomas (2003-08-19),
2. 6548502 - Dopamine D4 ligands for the treatment of novelty-seeking disorders (2003-04-15),
3. 5889010 - Benzimidazole derivatives having dopaminergic activity (1999-03-30),
4. 5883094 - Benzimidazolone derivatives with central dopaminergic activity (1999-03-16),

Title: Stevin H Zorn: Innovator in Pharmaceutical Treatments

Introduction

Stevin H Zorn is a notable inventor based in North Stonington, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurological and behavioral disorders. With a total of 4 patents to his name, Zorn's work has the potential to impact many lives.

Latest Patents

Zorn's latest patents include innovative pharmaceutical agents aimed at treating Parkinson's disease, ADHD, and microadenomas. The first patent focuses on the use of certain pyrido[1,2-a]pyrazine derivatives, also known as bis-azabicyclic compounds, for these conditions. The second patent introduces dopamine D4 ligands that provide methods for treating novelty-seeking disorders, such as pathological gambling and sex addiction. These inventions highlight Zorn's commitment to addressing complex health issues through scientific innovation.

Career Highlights

Stevin H Zorn is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to collaborate with some of the brightest minds in the industry, further enhancing his contributions to pharmaceutical research and development.

Collaborations

Zorn has worked alongside notable colleagues, including Mark Allen Sanner and Anton F Fliri. These collaborations have fostered an environment of innovation and creativity, leading to advancements in the treatment of various disorders.

Conclusion

Stevin H Zorn's contributions to the pharmaceutical field demonstrate his dedication to improving health outcomes through innovative treatments. His patents reflect a deep understanding of complex medical conditions and a commitment to finding effective solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…